Understand Diagnostic Market

Build Diagnostic Plan

Implement Diagnostic Plan

Diagnostic Tracking

New projects launched this month

Extension to European data and insights provision
PD-L1 landscape and tracker service expands to additional global markets
NTRK analysis and planning in the US
Global support for companion diagnostic planning
Health care provider tracking in the US

What's happening in the industry

FDA approval brings first gene therapy to the United States read on...

Gilead to buy Kite for promising cancer therapies in $12 billion deal read on...

A cancer conundrum: too many drug trials, too few patients read on...

Exosome Diagnostics, CareFirst partner to speed up coverage for diagnostic tests read on...

Cancer Treatment Centers of America, Foundation Medicine partner on precision medicine education initiative read on...

Bristol-Myers Squibb's Opdivo nabs MSI-H colorectal cancer nod, but it can't match Keytruda's umbrella approval read on...

Invivoscribe releases LeukoStrat CDx FLT3 mutation assay as CE-marked IVD assay kit read on...

Direct detection of early-stage cancers using circulating tumor DNA read on...

Read More News

What you might have missed

Article from G2 Intelligence - Companion diagnostics driving new model for pharma-Dx partnerships
Expert Insight - Liquid biopsy: clearing the barriers to support pharma, labs and patients
Listen to our latest webinar - Moving beyond the hype: the reality of NGS in oncology today and in the future
Have you read our most downloaded Expert Insight? Mystery solved! What is the cost to develop and launch a diagnostic?

Conferences we're attending

EU Society Pathology Congress

2-6 September 2017
Amsterdam, The Netherlands

Meet Us


8-12 September 2017
Madrid, Spain

Meet Us

Pharma CI Conference

12-13 September 2017
Parsippany, New Jersey, US

Meet Us


24-27 September 2017
Birmingham, UK

Meet Us